Back

PEARL, a non-interventional study on real-world use of alirocumab in German clinical practice: final study and cardiovascular subgroup data

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Preventive cardiology / Lipids Drug therapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Klaus G Parhofer

Ludwig Maximilians University, Munich (Germany)

20 More presentations in this session

Presentation thumbnail
Disconcordance between ESC prevention guidelines and observed lipid profiles in patients with known coronary artery disease
Doctor I. Dykun (Essen, DE)
Abstract
Presentation thumbnail
Statin treatment after acute coronary syndrome: long-term persistence and reasons for non-persistence
Doctor D. Huber (Umea, SE)
Abstract Slides
Presentation thumbnail
Predictive value of omega-3 polyunsaturated fatty acids (PUFAs) for cardiovascular- and all-cause mortality in chronic haemodialysis patients
Doctor Y. Kumada (Kasamatsu, JP)
Abstract
Presentation thumbnail
The association between apolipoprotein A1 and HDL-cholesterol with acute myocardial infarction is modified by plasma choline. A cohort study of patients with suspected stable angina pectoris
Doctor G. Svingen (Bergen, NO)
Abstract
Presentation thumbnail
Post-prandial remnant lipoprotein metabolism in sitosterolemia
Doctor H. Tada (Kanazawa, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 6 - Preventive cardiology / Lipids

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Lipid control in cardiovascular patients
thumbnail
Congress Presentation
Fix the plaque, fight the lipids: why low-density lipoproteins still matter after percutaneous coronary intervention
thumbnail
Congress Presentation
What’s new in LDL lowering?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources